Imatinib
Health movement in South Korea fights for universal access to medicines
Civil society in South Korea renewed its commitment to ensure universal access to medicines and public pharmaceutical production, building on decades of mobilization
COVID-19 treatment: SOLIDARITY trial is restarting with 3 drugs this time
The drug candidates for repurposing are imatinib, a cancer drug; infliximab, an antibody; and artesunate, an anti-malarial drug. The tests seek to explore possible drugs that can be repurposed to treat severely affected COVID-19 patients
